Brief Curriculum Vitae for Professor Nancy J. Devlin
April 2010
Further education and qualifications
BA Econ First class with Honours, University of Otago, 1984.
PhD in Economics, University of Otago, 1990.
Positions & employment
1984-5
Economist, New Zealand Institute of Economic Research, Wellington.
1985-7
Assistant Lecturer, Department of Economics, University of Otago
1987-1998
Lecturer, Department of Economics, University of Otago
1998-2000
Senior Lecturer in Health Economics, Department of Preventive and
Social Medicine, Dunedin School of Medicine, University of Otago
2001
Associate Professor, Department of Economics, University of Otago
2002
Fellow, King’s Fund, London.
2002-8
Professor of Economics, City University, London.
2005-7: Head of Department, Department of Economics
2008: Acting Dean of Social Sciences.
2009- present Director of Research, Office of Health Economics, London.
Other posts currently held
Honorary Chair, Cass Business School, London (2009 – present)
Honorary Chair, Centre for Health Economics, University of York (2009 – present)
Senior Associate, King’s Fund, London (2002-present)
MRC Board member, Methodology Research Panel (2009 – present).
Member of the Executive and Scientific Co-Chair (2005 – present), EuroQol Group,
Rotterdam.
Member, Department of Health PROMs stakeholder reference group (2009 – present)
Selected peer reviewed publications
 Devlin N, Tsuchiya A, Buckingham K, Tilling C. (2010) A uniform Time Trade
Off method for states better and worse than dead: feasibility study of the ‘lead
time’ approach. Health Economics (forthcoming).
 Devlin N, Parkin D, Browne J. (2010) Patient reported outcome measures in the
NHS: new methods for analyzing and reporting EQ-5D data. Health Economics
(forthcoming).
 O’Neill P, Devlin N (2010) An analysis of NICE’s ‘restricted’ (or ‘optimised’)
decisions. Pharmacoeconomics (forthcoming).
 Tilling C, Devlin N, Tsuchiya A, Buckingham K. (2010) TTO Valuations of
Health States Worse than Dead: a literature review and conceptual framework for
systematic analysis. Medical Decision Making (forthcoming).
 Parkin D, Rice N, Devlin N. (2010) Statistical analysis of EQ-5D profiles: does
the use of value sets bias inference? Medical Decision Making (forthcoming).
 Buckingham, K., Devlin, N. (2009) An exploration of the marginal utility of time
in health. Social Science and Medicine 68: 362-367.
 Appleby J, Devlin N, Parkin D, Chalkidou K, Buxton M. (2009) Searching for
cost effectiveness thresholds in the NHS. Health Policy 91(3):239-45.
 Dimakou S, Parkin D, Devlin N, Appleby J. (2009) Identifying the impact of
government targets on waiting times in the NHS. Journal of Health Care
Management Science. 12(1):1-10.
1







Buckingham K, Devlin N. (2006) A theoretical framework for TTO valuations of
health. Health Economics 5(10) 15 (10) 1149-54.
Parkin D., Devlin N. (2006) Is there a case for using visual analogue scale
valuations in Cost utility Analysis? Health Economics 15:653-664.
Dakin H., Devlin N., Odeyemi I. (2006) Yes, no or ‘yes, but…’: A multinomial
model of NICE decision-making. Health Policy 77:352-367.
Burge P, Devlin N, Appleby J, Rohr C, Grant J. (2005) Do patients prefer quicker
treatment? A discrete choice analysis of patients' stated preferences in the London
Patient Choice Project. Journal of Applied Health Economics and Health Policy
3(4): 183-194.
Devlin N, Parkin D. (2004) Does NICE have a cost effectiveness threshold and
what other factors influence its decisions? A binary choice analysis. Health
Economics 13(5): 437-52. GS = 261
Devlin N, Hansen, P, Kind P., Williams A. (2003) Logical inconsistencies in
survey respondents’ health state valuations – a methodological challenge for
estimating social tariffs. Health Economics 12(7): 529-544.
Derrett S, Devlin N, Hansen P, Herbison P. (2003) Prioritising patients for
elective surgery. A prospective study of clinical priority assessment criteria
(CPAC) in New Zealand. International Journal of Health Technology Assessment
19 (1):91-105.
Selected other publications:
 Devlin N, Appleby J. (2010) Getting the most out of PROMs: putting health
outcomes at the heart of NHS decision making. London: King’s Fund.
 Morris S, Devlin N, Parkin D. (2007) Economic analysis in health care. Wiley.
 Szende, A., Oppe, M., Devlin, N. (2007) EQ-5D valuation sets: an inventory,
comparative review and users' guide. Rotterdam: EuroQol Foundation. Springer.
Recent grants (PI: principal investigator, CI: collaborating investigator)
 PI on: Department of Health Policy Research Programme (PRP) grant (2010-11)
An interim EQ-5D-5L value set for England and development of EQ-5D-5L
valuation methods (awarded £325k).
 PI on: EuroQol Foundation (2009-10) Refining and testing the lead time TTO:
Pilot study (awarded £31k).
 PI on: Research grant awarded by a consortium of 13 British Pharmaceutical
companies (2009-10) NICE’s cost effectiveness threshold revisited (awarded
£65k).
 CI on: MRC (2010) Preparatory Research for re-Evaluating the EQ-5D Tariff
(PRET). (awarded £243k) (PI: A Tsuchiya, Sheffield)
 CI on: MRC (2010) Methods for estimation of NICE’s cost effectiveness
threshold. (awarded £351k) (PI: M Sculpher, York)
 CI on: Department of Health R&D (2009) PROMs analysis of hospital production
and efficiency: exploratory analysis. (awarded £60k). (PI: A Street, York)
 CI on: NIHR (2007-10) How patients choose and how providers respond. (PI: A.
Dixon, King’s Fund). (awarded £528k) [PR-HE-0107-10019]
2